Moneycontrol Be a Pro
Get App
SENSEX NIFTY
YOU ARE HERE > MONEYCONTROL > MARKETS > Pharmaceuticals > Nine Months - Advanced Enzyme Technologies

Advanced Enzyme Technologies

BSE: 540025|NSE: ADVENZYMES|ISIN: INE837H01020|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Nov 11, 16:00
178.05
0
VOLUME 50,736
LIVE
NSE
Nov 11, 16:00
178.05
-0.05 (-0.03%)
VOLUME 120,252
Download Annual Report PDF Format 2017 | 2016

Nine Months of Advanced Enzyme Technologies

------------------- in Rs. Cr. -------------------
Dec '18 Dec '17 Dec '16
Net Sales/Income from operations 166.16 152.28 120.18
Other Operating Income -- -- --
Total Income From Operations 166.16 152.28 120.18
EXPENDITURE
Consumption of Raw Materials 60.17 62.03 42.71
Purchase of Traded Goods -- -- --
Increase/Decrease in Stocks 3.70 5.20 -3.35
Power & Fuel -- -- --
Employees Cost 27.82 24.43 21.17
Depreciation 6.37 5.84 6.60
Excise Duty -- -- --
Admin. And Selling Expenses -- -- --
R & D Expenses -- -- --
Provisions And Contingencies -- -- --
Exp. Capitalised -- -- --
Other Expenses 35.39 30.18 26.93
P/L Before Other Inc. , Int., Excpt. Items & Tax 32.71 24.60 26.11
Other Income 3.83 4.19 3.70
P/L Before Int., Excpt. Items & Tax 36.53 28.79 29.81
Interest 1.92 2.37 2.20
P/L Before Exceptional Items & Tax 34.62 26.42 27.61
Exceptional Items -- -- --
P/L Before Tax 34.62 26.42 27.61
Tax 8.54 5.93 6.59
P/L After Tax from Ordinary Activities 26.08 20.50 21.02
Prior Year Adjustments -- -- --
Extra Ordinary Items -- -- --
Net Profit/(Loss) For the Period 26.08 20.50 21.02
Equity Share Capital 22.33 22.33 22.33
Reserves Excluding Revaluation Reserves -- -- --
Equity Dividend Rate (%) -- -- --
EPS Before Extra Ordinary
Basic EPS 2.34 1.84 9.52
Diluted EPS 2.33 1.83 9.52
EPS After Extra Ordinary
Basic EPS 2.34 1.84 9.52
Diluted EPS 2.33 1.83 9.52
Public Share Holding
No Of Shares (Crores) -- -- --
Share Holding (%) -- -- --
Promoters and Promoter Group Shareholding
a) Pledged/Encumbered
- Number of shares (Crores) -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- --
b) Non-encumbered
- Number of shares (Crores) -- -- --
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- --
- Per. of shares (as a % of the total Share Cap. of the company) -- -- --
Notes
Source : Dion Global Solutions Limited

Results of Advanced Enzyme

  • News
  • Results
  • Estimates
  • Analysis

Results of Pharmaceuticals Sector

  • News
  • Results
  • Estimates
  • Analysis
No news.
Quick Links for advancedenzymetechnologies
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.